Unresolved disorder model. using A ATOM 395 N AGLU 83 13.081 0.472 0.075 0.50 10.57 N Unresolved disorder model. using A ATOM 396 CA AGLU 83 14.335 0.648 0.808 0.50 10.86 C Unresolved disorder model. using A ATOM 397 C AGLU 83 14.561 2.078 1.310 0.50 10.81 C Unresolved disorder model. using A ATOM 398 O AGLU 83 15.449 2.310 2.131 0.50 11.00 O Unresolved disorder model. using A ATOM 399 CB AGLU 83 15.525 0.190 -0.045 0.50 11.32 C Unresolved disorder model. using A ATOM 400 CG AGLU 83 15.610 -1.320 -0.226 0.50 12.98 C Unresolved disorder model. using A ATOM 401 CD AGLU 83 14.578 -1.857 -1.202 0.50 14.90 C Unresolved disorder model. using A ATOM 402 OE1AGLU 83 14.497 -1.327 -2.326 0.50 16.15 O Unresolved disorder model. using A ATOM 403 OE2AGLU 83 13.857 -2.818 -0.850 0.50 17.42 O Unresolved disorder model. using A ATOM 404 N BGLU 83 13.080 0.483 0.084 0.50 10.74 N Unresolved disorder model. using A ATOM 405 CA BGLU 83 14.332 0.652 0.827 0.50 11.18 C Unresolved disorder model. using A ATOM 406 C BGLU 83 14.644 2.107 1.200 0.50 10.97 C Unresolved disorder model. using A ATOM 407 O BGLU 83 15.670 2.385 1.822 0.50 11.31 O Unresolved disorder model. using A ATOM 408 CB BGLU 83 15.499 0.024 0.056 0.50 11.80 C Unresolved disorder model. using A ATOM 409 CG BGLU 83 15.332 -1.470 -0.159 0.50 14.31 C Unresolved disorder model. using A ATOM 410 CD BGLU 83 16.590 -2.135 -0.674 0.50 17.87 C Unresolved disorder model. using A ATOM 411 OE1BGLU 83 17.506 -1.414 -1.117 0.50 20.05 O Unresolved disorder model. using A ATOM 412 OE2BGLU 83 16.664 -3.384 -0.633 0.50 19.92 O Unresolved disorder model. using A ATOM 525 N ALEU 99 13.184 -3.668 23.606 0.50 9.83 N Unresolved disorder model. using A ATOM 526 CA ALEU 99 14.387 -3.686 24.439 0.50 10.04 C Unresolved disorder model. using A ATOM 527 C ALEU 99 14.035 -3.856 25.913 0.50 10.16 C Unresolved disorder model. using A ATOM 528 O ALEU 99 14.666 -4.642 26.622 0.50 10.17 O Unresolved disorder model. using A ATOM 529 CB ALEU 99 15.229 -2.427 24.230 0.50 10.10 C Unresolved disorder model. using A ATOM 530 CG ALEU 99 16.474 -2.389 25.123 0.50 10.62 C Unresolved disorder model. using A ATOM 531 CD1ALEU 99 17.281 -3.671 24.987 0.50 12.52 C Unresolved disorder model. using A ATOM 532 CD2ALEU 99 17.322 -1.193 24.757 0.50 10.95 C Unresolved disorder model. using A ATOM 533 N BLEU 99 13.178 -3.661 23.603 0.50 9.95 N Unresolved disorder model. using A ATOM 534 CA BLEU 99 14.393 -3.642 24.424 0.50 10.31 C Unresolved disorder model. using A ATOM 535 C BLEU 99 14.062 -3.815 25.908 0.50 10.30 C Unresolved disorder model. using A ATOM 536 O BLEU 99 14.730 -4.572 26.616 0.50 10.38 O Unresolved disorder model. using A ATOM 537 CB BLEU 99 15.194 -2.354 24.173 0.50 10.38 C Unresolved disorder model. using A ATOM 538 CG BLEU 99 16.542 -2.159 24.884 0.50 11.68 C Unresolved disorder model. using A ATOM 539 CD1BLEU 99 16.345 -1.740 26.325 0.50 12.81 C Unresolved disorder model. using A ATOM 540 CD2BLEU 99 17.425 -3.403 24.798 0.50 12.89 C Unresolved disorder model. using A ATOM 1071 N AGLN 166 7.345 17.131 39.729 0.50 15.39 N Unresolved disorder model. using A ATOM 1072 CA AGLN 166 6.320 16.709 40.682 0.50 15.41 C Unresolved disorder model. using A ATOM 1073 C AGLN 166 5.079 16.226 39.936 0.50 15.03 C Unresolved disorder model. using A ATOM 1074 O AGLN 166 4.650 16.884 38.989 0.50 14.76 O Unresolved disorder model. using A ATOM 1075 CB AGLN 166 5.902 17.888 41.560 0.50 15.72 C Unresolved disorder model. using A ATOM 1076 CG AGLN 166 7.005 18.501 42.384 0.50 17.41 C Unresolved disorder model. using A ATOM 1077 CD AGLN 166 6.457 19.506 43.371 0.50 18.44 C Unresolved disorder model. using A ATOM 1078 OE1AGLN 166 5.244 19.582 43.584 0.50 20.05 O Unresolved disorder model. using A ATOM 1079 NE2AGLN 166 7.341 20.277 43.984 0.50 20.33 N Unresolved disorder model. using A ATOM 1080 N BGLN 166 7.337 17.108 39.732 0.50 15.31 N Unresolved disorder model. using A ATOM 1081 CA BGLN 166 6.354 16.670 40.720 0.50 15.21 C Unresolved disorder model. using A ATOM 1082 C BGLN 166 5.050 16.271 40.024 0.50 14.91 C Unresolved disorder model. using A ATOM 1083 O BGLN 166 4.558 17.024 39.184 0.50 14.57 O Unresolved disorder model. using A ATOM 1084 CB BGLN 166 6.084 17.799 41.719 0.50 15.57 C Unresolved disorder model. using A ATOM 1085 CG BGLN 166 7.347 18.411 42.311 0.50 16.56 C Unresolved disorder model. using A ATOM 1086 CD BGLN 166 8.054 17.472 43.264 0.50 17.52 C Unresolved disorder model. using A ATOM 1087 OE1BGLN 166 7.454 16.962 44.211 0.50 18.13 O Unresolved disorder model. using A ATOM 1088 NE2BGLN 166 9.343 17.248 43.029 0.50 18.38 N Unresolved disorder model. using A ATOM 2597 N AVAL 364 2.369 -1.324 7.031 0.50 9.35 N Unresolved disorder model. using A ATOM 2598 CA AVAL 364 3.055 -0.102 7.416 0.50 9.41 C Unresolved disorder model. using A ATOM 2599 C AVAL 364 2.815 0.944 6.342 0.50 9.17 C Unresolved disorder model. using A ATOM 2600 O AVAL 364 2.725 0.622 5.155 0.50 9.24 O Unresolved disorder model. using A ATOM 2601 CB AVAL 364 4.573 -0.315 7.617 0.50 9.54 C Unresolved disorder model. using A ATOM 2602 CG1AVAL 364 4.847 -1.485 8.568 0.50 9.60 C Unresolved disorder model. using A ATOM 2603 CG2AVAL 364 5.265 -0.517 6.284 0.50 10.13 C Unresolved disorder model. using A ATOM 2604 N BVAL 364 2.284 -1.284 6.980 0.50 9.08 N Unresolved disorder model. using A ATOM 2605 CA BVAL 364 3.161 -0.167 7.293 0.50 8.98 C Unresolved disorder model. using A ATOM 2606 C BVAL 364 2.860 0.955 6.297 0.50 8.89 C Unresolved disorder model. using A ATOM 2607 O BVAL 364 2.757 0.687 5.099 0.50 9.07 O Unresolved disorder model. using A ATOM 2608 CB BVAL 364 4.630 -0.625 7.139 0.50 8.59 C Unresolved disorder model. using A ATOM 2609 CG1BVAL 364 5.587 0.558 7.086 0.50 8.72 C Unresolved disorder model. using A ATOM 2610 CG2BVAL 364 5.016 -1.595 8.264 0.50 9.00 C 1